| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0005 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0005 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.0005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |